TY - JOUR
T1 - The first international consensus on mucous membrane pemphigoid
T2 - Definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators
AU - Chan, Lawrence S.
AU - Razzaque Ahmed, A.
AU - Anhalt, Grant J.
AU - Bernauer, Wolfgang
AU - Cooper, Kevin D.
AU - Elder, Mark J.
AU - Fine, Jo David
AU - Stephen Foster, C.
AU - Ghohestani, Reza
AU - Hashimoto, Takashi
AU - Hoang-Xuan, Thanh
AU - Kirtschig, Gudula
AU - Korman, Neil J.
AU - Lightman, Susan
AU - Lozada-Nur, Francina
AU - Peter Marinkovich, M.
AU - Mondino, Bartly J.
AU - Prost-Squarcioni, Catherine
AU - Rogers, Roy S.
AU - Setterfield, Jane F.
AU - West, Dennis P.
AU - Wojnarowska, Fenella
AU - Woodley, David T.
AU - Yancey, Kim B.
AU - Zillikens, Detlef
AU - Zone, John J.
PY - 2002
Y1 - 2002
N2 - Objective: We aimed to develop consensus-based recommendations for streamlining medical communication among various health care professionals, to improve accuracy of diagnosis and treatment, and to facilitate future investigations for mucous membrane pemphigoid. Participants: Because of the highly specific nature of this group of diseases, the 26 invited participants included either international scholars in the field of mucous membrane pemphigoid or experts in cutaneous pharmacology representing the 3 medical disciplines ophthalmology, oral medicine, and dermatology. Evidence: The first author (L.S.C.) conducted a literature search. Based on the information obtained, international experts who had contributed to the literature in the clinical care, diagnosis, and laboratory investigation for mucous membrane pemphigoid were invited to participate in a consensus meeting aimed at developing a consensus statement. Consensus Process: A consensus meeting was convened and conducted on May 10, 1999, in Chicago, III, to discuss the relevant issues. The first author drafted the statement based on the consensus developed at the meeting and the participants' written comments. The draft was submitted to all participants for 3 separate rounds of review, and disagreements were reconciled based on literature evidence. The third and final statement incorporated all relevant evidence obtained in the literature search and the consensus developed by the participants. The final statement was approved and endorsed by all 26 participants. Conclusions: Specific consensus-based recommendations were made regarding the definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators for mucous membrane pemphigoid. A system of standard reporting for these patients was proposed to facilitate a uniform data collection.
AB - Objective: We aimed to develop consensus-based recommendations for streamlining medical communication among various health care professionals, to improve accuracy of diagnosis and treatment, and to facilitate future investigations for mucous membrane pemphigoid. Participants: Because of the highly specific nature of this group of diseases, the 26 invited participants included either international scholars in the field of mucous membrane pemphigoid or experts in cutaneous pharmacology representing the 3 medical disciplines ophthalmology, oral medicine, and dermatology. Evidence: The first author (L.S.C.) conducted a literature search. Based on the information obtained, international experts who had contributed to the literature in the clinical care, diagnosis, and laboratory investigation for mucous membrane pemphigoid were invited to participate in a consensus meeting aimed at developing a consensus statement. Consensus Process: A consensus meeting was convened and conducted on May 10, 1999, in Chicago, III, to discuss the relevant issues. The first author drafted the statement based on the consensus developed at the meeting and the participants' written comments. The draft was submitted to all participants for 3 separate rounds of review, and disagreements were reconciled based on literature evidence. The third and final statement incorporated all relevant evidence obtained in the literature search and the consensus developed by the participants. The final statement was approved and endorsed by all 26 participants. Conclusions: Specific consensus-based recommendations were made regarding the definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators for mucous membrane pemphigoid. A system of standard reporting for these patients was proposed to facilitate a uniform data collection.
UR - http://www.scopus.com/inward/record.url?scp=0036120880&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036120880&partnerID=8YFLogxK
M3 - Review article
C2 - 11902988
AN - SCOPUS:0036120880
SN - 0003-987X
VL - 138
SP - 370
EP - 379
JO - Archives of Dermatology
JF - Archives of Dermatology
IS - 3
ER -